וירוס שמחסל תאים סרטניים

New Study: Harmless Virus Kills Some Cancers in Six Days Ronald Grisanti D.C.,.D.A.B.C.O., M.S. New study finds that six days is all it took for a common, non-disease-causing virus to kill cervical, breast, prostate AND squamous cell cancer cells in laboratory cultures. Craig Meyers, Ph.D., professor of microbiology AND immunology at Penn State College of Medicine has discovered that the virus, called adeno-associated virus type 2, OR AAV-2,although harmless to people can destroy cancerous cells in the body This specific virus is known to infect an estimated 80 percent of the population. Dr. Meyers research has found AAV-2 has no ill effects on healthy cells but appears to kill multiple types of cancer cells. "We believe that AAV-2 recognizes that the cancer cells are abnormal AND destroys them. This suggests that AAV-2 has great potential to be developed as an anti-cancer agent," Meyers said in a statement. How the Study Was Conducted Dr. Meyers AND colleagues first infected a batch of human cells with HPV, some strains of which cause cervical cancer. They then infected these cells AND normal cells with AAV-2. After six days, all the HPV-infected cells died. The same thing happened with cervical, breast, prostate AND squamous cell tumor cells. So many cancer therapies are as poisonous to healthy cells as they are to cancer cells. Dr. Meyer's commented that one of the most exciting findings is that AAV-2 appears to have no negative effects on healthy cells. Stay Informed AND Subscribe to Dr. Grisanti's Free Health Tip of the Week Reference: The study was presented June 20, 2005, at the 24th annual meeting of the American Society for Virology held June 18-22 at Penn State, University Park campus. Meyers C, Alam S, Mane M, Hermonat PL. Altered biology of adeno-associated virus type 2 AND human papillomavirus during dual infection of natural host tissue. Virology. 2001 Aug 15;287(1):30-9. ומה קרה עם זה מאז? (עברה שנה)

הנושא של וירוסים מחסלי סרטן לא חדש ופורסמו על כך הרבה מאמרים. יש כבר ניסויים בחולי סרטן, בעיקר בגידולי ראש. גם בהדסה ירושלים (פרופ' שמעון סלוין ואחרים) מנסים את זה. בינתיים אין בשורות.